Cancer Immunology, Immunotherapy Issues Research Articles in April 2023 Edition
March 19, 2023
March 19, 2023
BASEL, Switzerland, March 19 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its April 2023 edition:
Reviews:
* Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
* Lymphodepleting chemotherapy practices and effect on safety and e . . .
Reviews:
* Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
* Lymphodepleting chemotherapy practices and effect on safety and e . . .